Howard Rosen
Fondateur chez Evident Vascular, Inc.
Profil
Howard Rosen is the founder of Evident Vascular, Inc. Prior to that, he worked as the Vice President of Sales & Marketing at BG Medicine, Inc. He obtained his undergraduate degree from Northeastern University.
Postes actifs de Howard Rosen
Sociétés | Poste | Début |
---|---|---|
Evident Vascular, Inc.
Evident Vascular, Inc. Packaged SoftwareTechnology Services Evident Vascular, Inc. is a medical technology company that is developing an advanced intravascular ultrasound (IVUS) platform technology for peripheral vascular interventions, with future capability for coronary procedures. The company is based in San Jose, CA. The company leverages artificial intelligence (AI) to enable superior image interpretation and streamlined workflows, which has been designed to expand adoption of IVUS, driving increased market penetration and enabling improved clinical outcomes with faster, more accurate diagnosis and treatment decisions. The company was founded by Danielo Piazza, Patrick Philipps, Howard Rosen. Howard Rosen has been the CEO since incorporation. | Fondateur | - |
Anciens postes connus de Howard Rosen
Sociétés | Poste | Fin |
---|---|---|
BG MEDICINE, INC. | Sales & Marketing | - |
Formation de Howard Rosen
Northeastern University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BG MEDICINE, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Evident Vascular, Inc.
Evident Vascular, Inc. Packaged SoftwareTechnology Services Evident Vascular, Inc. is a medical technology company that is developing an advanced intravascular ultrasound (IVUS) platform technology for peripheral vascular interventions, with future capability for coronary procedures. The company is based in San Jose, CA. The company leverages artificial intelligence (AI) to enable superior image interpretation and streamlined workflows, which has been designed to expand adoption of IVUS, driving increased market penetration and enabling improved clinical outcomes with faster, more accurate diagnosis and treatment decisions. The company was founded by Danielo Piazza, Patrick Philipps, Howard Rosen. Howard Rosen has been the CEO since incorporation. | Technology Services |